Daiichi Sankyo, a global pharmaceutical company, is seeking novel in vivo models to understand pathological mechanisms in human disease. Indications of interest include microcirculatory disorders (e.g. INOCA, type II myocardial infarction, coronary microvascular dysfunction, etc.), dry aged-macular diseases, psychiatric diseases (neuroinflammatory related model for “CIAS of schizophrenia” and / or “MDD”) and neurodegenerative diseases.
Approaches of Interest:
- Mouse models are of interest for all indications
- Rabbit, pig or other large animal models are of...